U. Duenzinger

Successful systemic high‐dose ribavirin treatment of respiratory syncytial virus‐induced infections occurring pre‐engraftment in allogeneic hematopoietic stem cell transplant recipients

A. Berger, H. Serve, T. Wolf, 2013, Transplant infectious disease : an official journal of the Transplantation Society.

Abstract CT210: Trial in Process: Phase 1 studies of BI 1701963, a SOS1::KRAS Inhibitor, in combination with MEK inhibitors, irreversible KRASG12C inhibitors or irinotecan.

I. Waizenegger, T. Heffernan, N. Kraut, 2021, Clinical Trials.

Post-Transplant Maintenance With The Deacetylase Inhibitor Panobinostat In Patients With High-Risk AML Or MDS: Results Of The Phase I Part Of The Panobest Trial

H. Serve, A. Wolf, P. Bader, 2013 .

Early Disease Progression Predicts Poorer Survival in Patients with Follicular Lymphoma (FL) in the GALLIUM Study

W. Hiddemann, R. Marcus, G. Fingerle-Rowson, 2017 .